Viewing Study NCT03912233


Ignite Creation Date: 2025-12-25 @ 2:51 AM
Ignite Modification Date: 2026-02-02 @ 5:51 AM
Study NCT ID: NCT03912233
Status: COMPLETED
Last Update Posted: 2023-04-20
First Post: 2019-04-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis
Sponsor: Vertex Pharmaceuticals Incorporated
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-04-30
Start Date Type: ACTUAL
Primary Completion Date: 2019-12-10
Primary Completion Date Type: ACTUAL
Completion Date: 2019-12-10
Completion Date Type: ACTUAL
First Submit Date: 2019-04-10
First Submit QC Date: None
Study First Post Date: 2019-04-11
Study First Post Date Type: ACTUAL
Results First Submit Date: 2021-10-13
Results First Submit QC Date: None
Results First Post Date: 2023-04-20
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2020-12-11
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2023-03-29
Last Update Post Date: 2023-04-20
Last Update Post Date Type: ACTUAL